Steroid vs. yeast extract injection for patchy hair loss
Part of Skin clinical trials.
This trial compares two injections—triamcinolone (a steroid) and candida albicans antigen (a yeast extract)—to see which works better for alopecia areata (patchy hair loss). You might benefit if you have mild to moderate hair loss and haven't used other treatments recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have alopecia areata (patchy hair loss on your scalp).
- Your hair loss covers less than half of your scalp (SALT score under 50%).
- You have not used any topical or oral hair loss treatments in the past month.
- You are not pregnant or breastfeeding.
- You are not taking any medications that list hair loss as a side effect.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a cream (calcipotriol) with a steroid injection to treat patchy hair loss from alopecia areata. It aims to find which works better for people with mild to moderate scalp hair loss.
This trial tests if microneedling with either lactic acid, vitamin D3, or a steroid cream helps regrow hair in people with patchy alopecia areata (small bald spots).
This trial compares two creams—one with simvastatin (a cholesterol medicine) and one with a steroid—to see which works better for patchy hair loss caused by alopecia areata. It may help you if you have mild to moderate patchy hair loss and haven't used other treatments recently.
This trial tests a new topical cream for people with patchy alopecia areata (a type of hair loss). It aims to help regrow hair without using stronger medicines.
This study tests if a cream containing methotrexate (a medicine that affects the immune system) can help regrow hair in people with mild alopecia areata (patchy hair loss on the scalp). It compares the methotrexate cream to a standard treatment cream (minoxidil) to see which works better.
This study tests whether a new drug called LY4005130 can help regrow hair in adults with severe alopecia areata (an autoimmune condition causing patchy or widespread hair loss). The trial is looking for people who have lost a significant amount of hair and haven't seen it grow back on its own for at least 6 months.
Hear when a new Alopecia Areata trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.